0001232524-17-000073.txt : 20170308 0001232524-17-000073.hdr.sgml : 20170308 20170308173938 ACCESSION NUMBER: 0001232524-17-000073 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170306 FILED AS OF DATE: 20170308 DATE AS OF CHANGE: 20170308 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Jazz Pharmaceuticals plc CENTRAL INDEX KEY: 0001232524 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981032470 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4TH FLOOR, CONNAUGHT HOUSE STREET 2: ONE BURLINGTON ROAD CITY: DUBLIN STATE: L2 ZIP: 4 BUSINESS PHONE: 353-1-634-7800 MAIL ADDRESS: STREET 1: 4TH FLOOR, CONNAUGHT HOUSE STREET 2: ONE BURLINGTON ROAD CITY: DUBLIN STATE: L2 ZIP: 4 FORMER COMPANY: FORMER CONFORMED NAME: JAZZ PHARMACEUTICALS INC DATE OF NAME CHANGE: 20030513 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Treacy Paul CENTRAL INDEX KEY: 0001615763 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33500 FILM NUMBER: 17676129 MAIL ADDRESS: STREET 1: C/O JAZZ PHARMACEUTICALS PLC STREET 2: 4TH FL, CONNAUGHT HOUSE, 1 BURLINGTON RD CITY: DUBLIN STATE: L2 ZIP: 4 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2017-03-06 0 0001232524 Jazz Pharmaceuticals plc JAZZ 0001615763 Treacy Paul CONNAUGHT HOUSE, 1 BURLINGTON RD, FL. 4 DUBLIN 4 L2 IRELAND 0 1 0 0 SVP, Technical Operations Ordinary Shares 2017-03-06 4 S 0 355 131.9745 D 18108 D Ordinary Shares 2017-03-06 4 S 0 529 131.9749 D 17579 D Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $131.4935 to $131.9800. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $131.5330 to $131.9800. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. By: /s/Peter A Christou, as attorney in fact For: Paul Treacy 2017-03-08